How Life Sciences Companies Can Assess Quality and Value Strategy Progress

January 2021

Value-based care is creating new market demands for life sciences companies. Discern Health has worked with numerous life sciences clients to navigate these new demands and identify opportunities for further integration of quality and value into life sciences strategy. We have also identified concrete steps that life sciences companies can take to overcome barriers to change.

In our Integrating Quality and Value into Life Sciences Strategic Planning blog series, we define a framework that supports both internal change and external engagement to drive success in a value-based market environment. Part 2 of our series assesses the current adoption of quality strategy best practices among life sciences companies and discusses some of the specific steps companies can implement to advance the quality agenda.

Click here to review part 2 of the framework. Part 1 is available here, and part 3 will be posted in a subsequent newsletter.

For more information, please contact Gracelena Ignacio at gignacio@discernhealth.com.

New Report: Recommendations for Patient and Family Engagement in Measure Development

Harnessing the stories, ideas, and innovations of patient and caregiver partners is the key to making measurement meaningful. With support from the Patient-Centered Outcomes Research Institute (PCORI)...
Learn More

About

About

Capabilities

Capabilities

Contact

Contact Us

Insights

Insights

Guy D’Andrea Speaks About Innovative Payment Models

Click here to view the VIDEO